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Developmental progression in thymocytes is 
regulated by signal transduction nodes that inte-
grate inputs from cytokine and antigen receptors 
with those for ligands on stromal cells. Pro-
gression through stages as CD4CD8 double- 
negative (DN) precursors until the completion 
of TCR rearrangement and differentiation into 
CD4+CD8+ double-positive (DP) thymocytes 
involves signaling initiated by pre-TCR, IL-7R, 
and Notch (Hayday and Pennington, 2007). The 
Notch family consists of four conserved trans-
membrane receptors normally activated by 
ligands of the Delta/Jagged family expressed on 
neighboring cells; this activation by ligand 
releases an intracellular domain of Notch (ICN) 
from the plasma membrane to the nucleus to 
regulate expression of target genes such as Hes1 
and the proto-oncogene Myc (Maillard et al., 
2005). Notch1 regulates T lineage progression 
at specific steps that include proliferative expan-
sion of DN thymocytes and their differentia-
tion into DP cells (Radtke et al., 1999; Tanigaki 
et al., 2004; Maillard et al., 2005). How specific 
signal transduction pathways mediate these 
effects is not clear. One insight from an in vitro 
study has been that Notch ligation promotes 
glycolytic metabolism, and the Notch signal 
could be made superfluous by overexpression of 
Myr-Akt (Ciofani and Zúñiga-Pflücker, 2005). 
This constitutively active mutant of the ser-
ine-threonine kinase Akt sufficed to support 
enhanced cellular metabolism, proliferation, and 
generation of DP cells even in cultures on OP9 
cells lacking the Notch ligand DL1 (Delta-like 1; 
Ciofani and Zúñiga-Pflücker, 2005). This find-
ing suggested that pathways downstream from 
the lipid kinase phosphatidylinositol 3-kinase 
(PI3K) play key roles in Notch-induced thymo-
cyte progression in vivo and that Notch promotes 
this progression at the -selection checkpoint by 
regulating cellular metabolism.
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Notch plays critical roles in both cell fate decisions and tumorigenesis. Notch receptor 
engagement initiates signaling cascades that include a phosphatidylinositol 3-kinase/target 
of rapamycin (TOR) pathway. Mammalian TOR (mTOR) participates in two distinct biochemical 
complexes, mTORC1 and mTORC2, and the relationship between mTORC2 and physiological 
outcomes dependent on Notch signaling is unknown. In this study, we report contributions 
of mTORC2 to thymic T-cell acute lymphoblastic leukemia (T-ALL) driven by Notch. Condi-
tional deletion of Rictor, an essential component of mTORC2, impaired Notch-driven 
proliferation and differentiation of pre-T cells. Furthermore, NF-B activity depended on 
the integrity of mTORC2 in thymocytes. Active Akt restored NF-B activation, a normal 
rate of proliferation, and differentiation of Rictor-deficient pre-T cells. Strikingly, mTORC2 
depletion lowered CCR7 expression in thymocytes and leukemic cells, accompanied by 
decreased tissue invasion and delayed mortality in T-ALL driven by Notch. Collectively, 
these findings reveal roles for mTORC2 in promoting thymic T cell development and T-ALL 
and indicate that mTORC2 is crucial for Notch signaling to regulate Akt and NF-B.
© 2012 Lee et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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S473 was observed in studies in which rictor was deleted after 
differentiation of thymocytes to a positively selecting DP stage 
(Lee et al., 2010) or when the CD4-Cre transgene, which acts 
in late DN cells, was used (Delgoffe et al., 2011). Thus, it was 
possible that the capacity of alternative kinases such as DNA-
PKs (Feng et al., 2004), PKC- (Kawakami et al., 2004), or 
IB kinase  and TANK (TRAF-associated NF-B activator)-
binding kinase 1 (Xie et al., 2011) to execute direct Akt HM 
phosphorylation might provide sufficient activity in thymo-
cytes. Nonetheless, the requirement for Akt in thymic on-
togeny before -selection and a connection of Notch to Akt 
do not establish what quantitative level of Akt activity might 
be needed for specific aspects of the process. Accordingly, it 
is not clear whether mTORC2 or HM phosphorylation of 
Akt impacts thymocyte development or pathological conse-
quences of sustained, high-level Notch signaling.
Herein, we used the in vitro model system that compares 
stromal cells (OP9) that express the Notch ligand DL1 (OP9-
DL1) to isogenic OP9 controls (Ciofani and Zúñiga-Pflücker, 
2005) to identify outcomes that are changed by a Notch sig-
nal. Signaling, size, glycolysis, proliferation, and differentiation 
of WT and mTORC2-depleted thymocytes were compared 
after culture on OP9 ± DL1. Because lack of mTORC2 im-
paired Notch-induced proliferation and differentiation of DN 
into DP thymocytes, we analyzed the impact of the loss of 
function mutation on thymic development and disease progres-
sion of T-ALL driven by Notch. Overall, our results indicate 
that mTORC2 relays a Notch signal to NF-B to regulate 
the Ccr7 gene, contributing to thymic T cell development 
and T-ALL.
RESULTS
A loss of function model for PDK2 activity in thymocytes
To investigate the role of mTORC2 in Notch effects on thy-
mocytes, an essential subunit was conditionally depleted by 
breeding Rictorfl/fl mice with transgenic mice expressing Cre 
controlled by the Lck proximal promoter (Lck-Cre+ Rictorfl/fl; 
abbreviated hereafter as conditional KO [cKO]). Cells from 
these mice were then compared with WT controls that in-
cluded Lck-Cre+ RictorWT/WT as well as Rictorfl mice lacking a 
Cre transgene (no difference of results was observed between 
these two classes of WT control). Excision of the conditional 
allele by Cre was observed early in T ontogeny, starting at the 
DN2 stage, and resulted in Rictor deletion in cKO thymo-
cytes and peripheral T cells but not in the non-T populations 
(Fig. 1, A and B). Moreover, Rictor protein was depleted in the 
cKO thymocytes, whereas mTOR did not change (Fig. 1 C). 
TORC2 and other serine-threonine kinases can phosphorylate 
Akt at its C-terminal HM (S473; Feng et al., 2004; Kawakami 
et al., 2004; Xie et al., 2011). Loss of Rictor eliminated most 
PDK2 activity toward Akt S473 both in resting and co-
stimulated thymocytes but did not substantially reduce Akt 
phosphorylation at T308, the PDK1 target site (Fig. 1 D). Also, 
Akt enzymatic activity was markedly decreased in the rictor-
depleted thymocytes (Fig. 1 E). Consistent with these effects, 
phosphorylation of the Akt substrate FoxO1/3a was impaired 
Physiological activation of Akt involves the generation 
of phosphatidylinositol 3, 4, 5-triphosphate (PIP3) by PI3K, 
recruitment of Akt to membranes via its pleckstrin homology 
(PH) domain, and obligate T-loop (T308) phosphorylation 
by PDK1 (PI3K-dependent kinase 1; Vanhaesebroeck and 
Alessi, 2000). Inactivation of PDK1 early in T lineage ontog-
eny blocked thymic differentiation at a DN stage, and PDK1-
null pre-T cells did not respond to Notch-induced trophic, 
proliferative, or differentiating signals (Hinton et al., 2004; 
Kelly et al., 2007). Similar phenotypes were observed when 
the genes encoding multiple isoforms of Akt were inactivated 
in T lineage cells (Juntilla et al., 2007; Mao et al., 2007). 
These results indicate that expression of Akt and the capacity 
to execute its T-loop phosphorylation by PDK1 are vital 
at the DN to DP transition. The ability of Notch to drive 
PI3K/Akt-related pathways is notable because in addition to 
its roles in thymic development, Notch is important in onco-
logic pathophysiology (Weng et al., 2004; O’Neil et al., 2006). 
Gain of function mutations of Notch are implicated in a variety 
of cancers, including over half of human T-cell acute lympho-
blastic leukemia (T-ALL; Weng et al., 2004). Consistent with 
an important role of lipid signaling via PIP3, a major tumor 
suppressor impacts the pathway by dephosphorylating PIP3 
to regenerate PIP2 (Cully et al., 2006), and unbiased screens 
identified Akt mutation and loss of the PIP3-phosphatase 
PTEN (phosphatase and tensin homologue) as major contrib-
utors in malignancy (Li et al., 1997; Eng, 2003; Carpten et al., 
2007; Maser et al., 2007; Gutierrez et al., 2009). Use of a trans-
dominant inhibitor of NF-B activation indicated that this 
transcriptional pathway is a key relay activated by Notch in 
T-ALL (Vilimas et al., 2007), but little is known about crucial 
intermediaries in the process.
Akt can also be phosphorylated at a C-terminal hydro-
phobic motif (HM; “S473”) by activities referred to as 
PDK2 (Chan and Tsichlis, 2001). In addition to the original 
rapamycin-sensitive complex containing mammalian target 
of rapamycin (mTOR), complex 1 (mTORC1), this kinase 
participates in a second complex, mTORC2 (Sarbassov et al., 
2004), which, unlike mTORC1, is resistant to acute rapamy-
cin inhibition (Sarbassov et al., 2006). MTORC2, whose integ-
rity requires rictor, mSIN1, and mLST8 subunits in addition to 
mTOR, appeared to be the sole PDK2 responsible for Akt 
HM phosphorylation in several cancer cells and mouse 
embryonic fibroblasts (Sarbassov et al., 2005; Guertin et al., 
2006; Shiota et al., 2006). Deficiency in any subunit impacted 
mTORC2 activity as a PDK2 toward substrates such as Akt, 
SGK1, and protein kinase C (PKC) isoforms (Guertin et al., 
2006; Jacinto et al., 2006; García-Martínez and Alessi, 2008). 
Whereas PH domain binding to PIP3 and T308 phosphory-
lation of Akt by PDK1 are essential for turning on the kinase 
(Sarbassov et al., 2005; Laplante and Sabatini, 2009), Akt HM 
phosphorylation at most modulates Akt activity. Depletion of 
rictor impaired Akt S473 phosphorylation in resting and acti-
vated mature T cells (Lee et al., 2010; Delgoffe et al., 2011). 
However, residual HM phosphorylation of Akt consistent 
with the capacity of other enzymes to phosphorylate the Akt 
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and there was only a modest difference between 
WT- and cKO-derived cells as to frequencies of 
NK1.1+ and Gr1+ cells (Fig. 2, D and E). Further-
more, purified DN3 cells yielded >98% Thy1+ 
products from Rictor cKO as well as WT thymi after 
co-culture with OP9 (not depicted). As in the work con-
necting mTOR to Notch, these cultures were supplemented 
with IL-7 (Ciofani and Zúñiga-Pflücker, 2005). In the ab-
sence of IL-7, DN thymocytes barely multiplied in response 
to DL1, but in any case, Notch-induced differentiation and 
proliferation of the cKO DN cells were less than controls 
(Fig. 2 F and not depicted). These results demonstrate a 
requirement for mTORC2 in the proliferation and differen-
tiation of pre-T cells in a Notch-dependent setting. Further-
more, although myriad receptors, including the pre-TCR 
and IL-7R, signal in this system, the findings suggest that the 
need for Rictor represents PI3K and mTORC2 downstream 
from Notch in attainment of full proliferation and DN to 
DP progression.
Notch promoted pre-T cell metabolism and thereby sur-
vival and proliferation; the rapamycin sensitivity of these pro-
cesses implicated mTOR but cannot definitively distinguish 
whether the signals are relayed by mTORC1, mTORC2, or 
both (Ciofani and Zúñiga-Pflücker, 2005; Sarbassov et al., 2006; 
Kelly et al., 2007; Lee et al., 2010). Consistent with prior analy-
ses, we observed increases in the size (forward scatter [FSC] 
of light) and glycolytic rate of WT DN thymocytes cultured 
on OP9-DL1 as compared with OP9 without Notch ligand 
(Fig. 2, G and H). Despite their reduced proliferation, cKO 
DN cells were comparable with WT controls in measurements 
of size and glycolytic rate (Fig. 2, G and H). Notch-driven 
PI3K suppresses caspase-3 cleavage in pre-T cells, and results of 
rapamycin inhibition along with loss of function for PDK1 
suggest that PDK1 and mTOR are important for Notch 
inhibition of apoptosis (Ciofani and Zúñiga-Pflücker, 2005; 
(Fig. 1 F). Increased Akt activity can potentially enhance 
mTORC1 (Kelly et al., 2007; Dan et al., 2008; Laplante and 
Sabatini, 2009) but in Rictor-deficient thymocytes exhibited 
no decrease in phosphorylation of S6K1 downstream from 
mTORC1 or its target S6. PDK2 activity is robust in the ab-
sence of mTOR in some settings (Bentzinger et al., 2008; Xie 
et al., 2011), and our data suggest that there may be a secondary 
PDK2 in thymocytes. Nonetheless, mTORC2 served as the 
main kinase for Akt S473 in thymocytes, and this HM phos-
phorylation enhanced Akt activity and FoxO phosphorylation.
Notch-driven proliferation and differentiation  
of thymocytes depend on Rictor
To analyze roles of mTORC2 and HM phosphorylation of 
Akt in Notch-driven thymocyte progression, we used an 
in vitro system with OP9 stromal cells expressing the Notch li-
gand DL1 (Fig. 2 A; Ciofani and Zúñiga-Pflücker, 2005). As 
expected, WT DN cells exhibited rapid proliferation (30-
fold increase) and differentiation into DP thymocytes (30–40% 
of cells) when cultured on the OP9-DL1 (Fig. 2, B and C). 
In contrast, Rictor-null DN cells proliferated and differenti-
ated far less efficiently on OP9-DL1 (Fig. 2, B and C). To 
test whether Notch ligand was less able to restrict the DN 
population to T lineage fates in the Rictor-null thymocytes, 
Thy1 was measured on nonstromal cells in OP9-DL1 cultures, 
but 98–99% of cells were Thy1+ (Fig. 2, D and E). The few 
DN1 and DN2 cells at the outset of a culture need ongoing 
Notch signals to adopt or maintain a T lineage fate (Schmitt 
et al., 2004). A substantial majority of Rictor cKO cells at the 
end of cultures on OP9 without Notch ligand were Thy1+, 
Figure 1. Akt S473 phosphorylation and Akt activity in 
thymocytes depend on Rictor. (A and B) Cre-driven Rictor 
deletion. (A) DNA was prepared from thymocytes and periph-
eral lymphoid cells fractionated using Thy1. Shown is a PCR 
detecting Rictor of WT (+), conditional (fl), and deleted () 
alleles from the indicated mice (WT, Lck-Cre Rictorfl/+; cKO, 
Lck-Cre+ Rictorfl/fl; representative of three replicates). (B) Shown 
is a result (one of two) for PCR detecting Rictor alleles, as in A, 
using DNA from DN thymocyte subsets flow sorted by CD25 
and CD44 expression on CD4CD8 cells. (C) Immunoblot 
analysis of rictor and mTOR in thymocytes, normalized to  
-tubulin signal (one of three independent experiments). (D) Rictor- 
null thymocytes were stimulated with 2.5 µg/ml anti-CD3 and 
2.5 µg/ml anti-CD28 and analyzed by immunoblots with the 
indicated antibody (one representative of four independent 
experiments, except n = 2 for P-Akt(T308)). (E) Using GSK-
3/ as a substrate, enzymatic activity was assayed in the 
anti-Akt complexes immunoprecipitated from thymocyte  
lysates. Shown is an anti-P–GSK-3 immunoblot result (one 
representative of two independent experiments). IP, immuno-
precipitation. (F) P-FoxO expression in Rictor cKO cells, show-
ing the (P-)FoxO1 bands after immunoblot analyses as in D.
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Figure 2. Notch-driven proliferation and differentiation of DN thymocytes but not their glycolytic rate require Rictor. (A) The assay system. 
Purified CD4CD8 thymocytes were cultured on isogenic stromal cells bearing Notch ligand (OP9-DL1) or control OP9 cells in the presence or absence of 
IL-7. (B) Effect of Rictor on DN thymocyte differentiation. Shown is a CD4 and CD8 flow analysis of DN cells cultured with OP9-DL1 or control OP9 mono-
layers for 6 d; the inset numbers indicate the percentage of CD4+CD8+ (DP) cells (one representative result of four independent replicates). (C) DN thymo-
cyte proliferation after Rictor deletion. Shown are the means (±SEM; n = 4 experiments) for thymocyte expansion in the culture (fold increase = cells 
recovered/input DN cells). *, P < 0.05. (D and E) DN thymocytes cultured as in B were analyzed for surface markers of T-, myeloid-, and NK/NKT-lineage 
progeny (D–F: one result of four samples, from two independent experiments, each performed in duplicate). (F) Purified DN thymocytes were cultured for 
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(Fig. 3, C–E). To test whether active Akt that cannot be 
phosphorylated at the HM could fully replace the signals 
lacking in the absence of mTORC2, Akt(DA) (T308D 
S473A) was also transduced into the cKO DN cells. Intrigu-
ingly, this form of Akt enhanced proliferation to an extent 
similar to Akt(DD) but provided little rescue of differentiation 
(Fig. 3, C–E). These data indicate that mTORC2 relays Notch 
signaling in part by phosphorylation of Akt S473 in thymo-
cytes and suggest that there are distinct activity–response 
curves for differentiation and proliferation of pre-T cells.
mTORC2 regulates nuclear localization  
of NF-B in thymocytes
Nuclear translocation of the transcription factor NF-B is 
triggered by both the pre-TCR and Notch during thymic 
development (Voll et al., 2000; Vacca et al., 2006), so we 
analyzed whether mTORC2 impacts thymocyte NF-B. 
Nuclear NF-B DNA-binding activities were decreased in 
the cKO thymocytes compared with controls (Fig. 4 A). Of 
note, ample nuclear NF-B was detected after 2-d culture in 
DL1-stimulated WT DN thymocytes but not in the cKO 
cells or those cultured on OP9 alone in the co-culture system 
with IL-7 present and all factors the same except the addi-
tional Notch ligand (Fig. 4 B). To explore the impact of this 
defect, we measured expression of several NF-B target 
genes. Expression of Bcl2a1 and Nfkb2 was decreased in both 
DN thymocytes of cKO mice (Fig. 4 C) and Rictor-deficient 
DN cells cultured on OP9-DL1 (Fig. 4 D). Antibody block-
ing experiments demonstrated that the DNA–protein com-
plexes contained predominantly p50:RelA heterodimers 
(Fig. 4 E). Thus, mTORC2 regulates NF-B activity and 
target gene expression in resting thymocytes and those stimu-
lated via Notch.
In PTEN-deficient cells, Akt can use a Raptor-dependent 
mechanism to activate NF-B signaling by phosphorylating 
IKK-, but the generality of this connection or the ability of 
Akt to increase NF-B in the nucleus is not entirely clear 
(Ozes et al., 1999; Romashkova and Makarov, 1999; Jones 
et al., 2005; Dan et al., 2008). To test whether the NF-B in 
Rictor-depleted thymocyte nuclei could be restored by acti-
vated Akt, DN cells were transduced with Akt and cultured 
on OP9-DL1. Akt(DD) induced NF-B nuclear localization 
in the cKO DN cells of a magnitude comparable with that of 
WT cells (Fig. 4 F). In contrast, Akt(DA) failed to restore the 
NF-B nuclear induction in the cKO DN thymocytes. We 
infer that mTORC2 is a relay vital for Notch induction of 
NF-B in thymocytes, acting at least in part through Akt 
HM phosphorylation as an intermediary.
Kelly et al., 2007). However, Rictor-deficient thymocytes 
did not exhibit increased activated caspase-3 compared with 
WT controls (Fig. 2 I). Thus, the impaired multiplication and 
DN to DP transition of PDK2-deficient thymocytes appear 
to be uncoupled from suppression of atrophy (cell size and 
glycolysis) and caspase activation.
Akt mediates mTORC2 signaling downstream from Notch
To test whether the DN thymocyte fraction exhibited any 
abnormality of Akt activity or FoxO phosphorylation in a 
setting more closely modeled on the Notch-driven differen-
tiation system, CD4CD8 cells were cultured on OP9-DL1 
stromal cells for 2 d. Although cell numbers were limiting 
even with Notch ligand, purified DN thymocytes cultured 
on Notch ligand–bearing stromal cells exhibited substantially 
reduced phosphorylation of the Akt HM and of FoxO1/3a in 
Rictor-deficient samples (Fig. 3 A). Of note, the Notch 
ligand on the OP9-DL1 stromal cells enforced essentially 
complete maintenance of T lineage commitment, and little 
differentiation to DP status was evident. Moreover, the amounts 
of cleaved intracellular Notch and S6 phosphorylation in the 
WT and cKO thymocytes of these cultures were similar 
(Fig. 3 A). We conclude that stimulus-induced Akt activity 
in pre-T cells depends on their mTORC2.
We next transduced DN cells to test whether activated 
Akt could restore normal proliferation or differentiation of 
Rictor-depleted thymocytes in the OP9-DL1 co-culture sys-
tem. In line with earlier work (Ciofani and Zúñiga-Pflücker, 
2005), we tested Myr-Akt, which bypasses the physiological 
role of PH domain–mediated binding to PIP3 (Fig. 3 B). 
Transduction with Myr-Akt enhanced differentiation for 
WT DN cells and drove cKO DN cells to develop into DP 
cells as efficiently as their WT counterparts (Fig. 3 B). As ex-
pected (Ciofani and Zúñiga-Pflücker, 2005), Myr-Akt drove 
WT DN cells to proliferate and develop into DP cells even 
in the absence of Notch ligand and drove cKO thymocytes 
cultured on OP9-DL1 to yield as many DP cells as their WT 
counterparts (not depicted). We next used two isogenic vari-
ants of constitutively active Akt that retains its PH domain, 
one of which encodes phosphomimetic aspartates at both the 
T loop and HM phosphorylation sites (Akt(DD): T308D 
S473D). Transduction of DN thymocytes with Akt(DD) 
only weakly induced proliferation and differentiation into 
DP cells in the absence of Notch ligand but enhanced these 
processes in WT cells cultured on OP9-DL1 (Fig. 3, C–E). 
Importantly, Akt(DD) substantially increased both prolifera-
tion and the efficiency of differentiation of Notch-stimulated 
Rictor-deficient DN thymocytes, attaining almost WT values 
6 d on OP9-DL1 or OP9 cells in the presence or absence of IL-7 and analyzed by flow cytometry. Shown are the CD4 versus CD8 profiles of cells in the 
viable lymphoid gate (one result of two experiments). (G) WT and cKO DN thymocytes were cultured for 2 d on OP9-DL1, and histograms of their FSC 
were compared. Shaded histograms, cultured on OP9; line histograms, cultured on OP9-DL1, with mean light intensity (MLI) values shown (one result  
of four experiments). (H) Mean (±SEM; n = 2 independent experiments) glycolytic rates in purified DN cells cultured for 2 d on OP9 or OP9-DL1 cells.  
*, P < 0.05. (I) Activated caspase-3 in DN thymocytes co-cultured with OP9-DL1 (6 d). Shown are the flow histograms for cleaved caspase-3 in the viable 
lymphoid gate from a representative experiment (two independent replicates); inset numbers represent the percentage of positive events.
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In contrast, the FoxO targets Il7r and Sell were present at lower 
levels, whereas S1p1 was not. Notably, expression of the 
NF-B–regulated gene Ccr7 was substantially decreased both 
in DN thymocytes from cKO mice (Fig. 4 G) and in Rictor-
deficient DN cells cultured on OP9-DL1 (Fig. 4 H). Fur-
thermore, chemotaxis of cKO cells toward CCL19, a CCR7 
ligand, was decreased compared with WT controls (Fig. 4 I). 
These results indicate that mTORC2 is important for Notch-
initiated, NF-B–dependent gene expression but also suggest 
an interplay with FoxO transcription factors.
To explore further the functional implications of this de-
pendency of Notch-induced NF-B on mTORC2, we quan-
titated expression of several genes regulated by Notch, FoxO, 
or NF-B. Hes1, a direct target of the transcriptional complex 
of cleaved, intracellular Notch with CSL-MAML, was margin-
ally decreased in purified DN thymocytes analyzed directly 
ex vivo (Fig. 4 G). Similarly, messenger RNA (mRNA) encod-
ing the pre-TCR  chain (Ptcra, encoding pT) decreased only 
marginally (Fig. 4 G), and the expression of pT and Notch 
proteins was unaffected by lack of Rictor (not depicted). 
Figure 3. Active Akt is epistatic to Rictor in Notch-driven pre-T cell differentiation and proliferation. (A) Purified DN thymocytes cultured for 
2 d on OP9-DL1 cells were analyzed by immunoblotting (one result of two independent experiments; cultures of OP9 without DL-1 yield too few cells for 
these analyses). (B–E) Purified DN cells were cultured for 6 d on OP9-DL1 or OP9, during which time they were transduced with vector, Myr-Akt, Akt(DD), 
and Akt(DA), and then analyzed. (B and C) Shown are CD4 and CD8 profiles in the viable lymphoid GFP+ gates in one experiment representative of three 
independent replicates, along with Western blots of Akt or the HA tag on Akt(DD) and Akt(DA), as indicated. Myr-Akt was detected as a band migrating 
slower than endogenous Akt. (D) Mean (±SEM) efficiency of differentiation into DP thymocytes in the GFP+ gate for the three replicate experiments of  
B and C, normalized to vector-transduced WT cells grown on OP9-DL1. *, P < 0.05. (E) Mean (±SEM) population increases, with normalization and replicates 
as in D. *, P < 0.05.
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(Fig. 5 C). In contrast, neither proliferation nor differentia-
tion was increased by transduction of IKK2(SSEE) (Fig. 5, 
B and C), an IKK2 mutant with phosphomimetic mutations at 
its T loop activating residues and constitutive activity (Fig. 5 D; 
Carter et al., 2001). Strikingly, the combination of IKK2(SSEE) 
with reduction of FoxO1 and FoxO3 by RNAi reproducibly 
promoted increases in both the prevalence and yield of DP 
products (Fig. 5 B). The inability to restore complete nor-
malcy indicates that yet further targets downstream from 
mTORC2 and Akt remain to be identified. Nonetheless, 
these findings provide evidence that the FoxO and classical 
NF-B signaling pathways collaborate to promote the DN to 
DP conversion downstream from mTORC2.
Role of mTORC2 in T lineage ontogeny
We next examined whether rictor depletion in DN thymo-
cytes resulted in any alteration of the T lineage in vivo. 
Both CD4+ and CD8+ T cell numbers were reduced in the 
Evidence that the rictor effect on DN thymocytes involves 
concerted actions of the NF-B and FoxO pathways
To explore the respective contributions of the FoxO1/3a and 
NF-B pathways, we first tested whether excess FoxO could 
impact DN cells cultured on OP9-DL1. Lack of phosphory-
lation of FoxO1/3a impairs their 14-3-3 protein-mediated 
egress from nuclei. This failure should be phenocopied by 
use of FoxO3(AAA), a FoxO mutant with alanine substitu-
tions at the kinase target sites (Nakamura et al., 2000; Waugh 
et al., 2009). When DN thymocytes were transduced with 
this FoxO mutant, a substantial decrease in proliferative ex-
pansion of the pre-T cells compared with controls was observed 
(Fig. 5 A), so we next tested whether decreasing FoxO1/3a 
could reverse the impairment of rictor-deficient cells. An 
RNA interference (RNAi)–driven decrease in FoxO1 and 
FoxO3 led to a very modest but reproducible improvement 
in the efficiency of DP differentiation in the cultures (Fig. 5 B) 
and enhanced the multiplication of Rictor cKO thymocytes 
Figure 4. Notch-induced NF-B requires 
mTORC2. (A) Nuclear extracts prepared from 
thymocytes of individual mice were analyzed 
by EMSA for nuclear NF-B. Binding of the 
Oct-1 transcription factor was used as a load-
ing control. (A, B, and E: one result is shown, 
representative of two independent experi-
ments.) (B) Purified CD4CD8 thymocytes 
were analyzed by EMSA for nuclear NF-B 
after 2-d culture on OP9 or OP9-DL1 cells  
in the presence of IL-7. (C and D) RNA  
isolated from purified DN thymocytes (C) or 
CD4CD8 cells (D) cultured for 2 d on OP9-
DL1 cells was analyzed by qRT2-PCR for NF-B 
target genes. Shown are the mean (±SEM) 
concentrations of mRNA in cKO relative to 
WT, averaging five (C) and two (D) indepen-
dent replicate experiments. *, P < 0.05.  
(E) Nuclear extracts of WT DN thymocytes 
cultured for 2 d on OP9-DL1 (B) were ana-
lyzed by EMSA for nuclear NF-B after incu-
bation with antibodies (Ab) against the 
indicated NF-B/Rel proteins or nonimmune 
IgG control. (F) Purified DN thymocytes were 
transduced with vector, Akt(DD), and Akt(DA) 
while cultured on OP9-DL1 cells for 2 d. EMSAs 
were performed using nuclear proteins of 
transduced cells after purifying Thy1.1+ cells. 
Of two independent experiments, one result is 
shown. (G and H) Effects on target genes in 
Rictor-null thymocytes. RNA isolated from 
purified DN thymocytes (G; five independent 
experiments) or DN cells cultured for 2 d on 
OP9-DL1 (H) were analyzed by qRT2-PCR. As 
in C and D, mean (±SEM) values for the ratios 
of expression in Rictor cKO samples, each 
compared with WT in the same replicate 
experiment, are shown (H: two biologically independent experiments, each in duplicate). *, P < 0.05. (I) Rictor-null thymocyte chemotaxis to CCL19, a 
CCR7 ligand. Shown are mean (±SEM) values for WT and cKO thymocytes, averaging two independent experiments, each with duplicate samples, after 
enumeration and flow cytometric subset determination. *, P < 0.05.
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Together, the results indicate a requirement for 
mTORC2 in achieving normal rates of develop-
mental progression in T cell ontogeny.
DN thymocytes can be further subdivided on 
the basis of CD44 and CD25 expression. For analy-
ses of these DN subsets, we used both the Lck-Cre 
transgene and, to complement these results, a Vav-
Cre transgene (Table 1) that drives deletion before 
specification of T lineage fate (de Boer et al., 2003). 
Increases in CD44CD25+ DN3 cells relative to 
their CD44CD25 DN4 successors were observed 
in thymi made Rictor null by each method (Fig. 6, 
G and H), suggesting an impaired DN3/DN4 tran-
sition. Notch signaling directs and then cements a T lineage 
fate at the DN1 and DN2 stages (Schmitt et al., 2004), so it 
was intriguing that a decrease in DN1 cells also was observed 
(Fig. 6, G and H). We further analyzed the cell-intrinsic im-
pairment of thymocyte ontogeny analyzing the competitive 
fitness of Rictor-deficient thymocytes developing together with 
WT counterparts in vivo. After transfer of bone marrow from 
WT or cKO mice along with fixed portions of marrow from 
allotypically disparate WT mice, marrow reconstitution was 
equivalent (not depicted), but the fitness of WT T lineage cells 
within the thymus was 16-fold greater than that of mTORC2-
deficient counterparts generated using the Vav-Cre transgene 
(Fig. 7, A and B). Detailed thymocyte subset analyses showed 
the decrease in DN1 rictor-deficient cells and impediment to 
progression to a DP stage (Fig. 7, C–E). We conclude that 
Rictor is required in cell-autonomous processes of normal 
T cell development in the thymus, both in establishing normal 
numbers of cells and in promoting the DN to DP transition.
The findings suggesting a defect of proliferative expansion 
led us to measure the effect of Rictor deficiency on thymocyte 
spleen and lymph nodes of cKO mice (Fig. 6, A and B). 
Homeostatic expansion driven by T cell underproduction 
leads to increased frequencies of CD44hi cells, and the prev-
alence of CD44hi and CD25+ T cells was much higher 
among the peripheral T cells of cKO mice as compared 
with WT controls, especially for CD8+ T cells (not depicted). 
These findings suggested that thymic development was re-
duced and that mTORC2 function during thymocyte ontog-
eny is essential for normal populations of conventional T cells. 
Consistent with this, cKO mice had reduced thymic cellu-
larity (Fig. 6 C and Table 1). Because the Notch-driven pro-
liferation and differentiation of DN into DP cells depended 
on mTORC2 in the OP9-DL1 system, we quantitated thy-
mocyte subpopulations. Cell numbers in each major thymo-
cyte subset were reduced in Rictor cKO animals, but it was 
notable that the prevalence of DN thymocytes increased 
while that of their DP descendants decreased (Fig. 6, D–F). 
This finding provides evidence that the efficiency of this 
developmental transition in situ was reduced by Rictor defi-
ciency, consistent with the findings with OP9-DL1 cultures. 
Figure 5. Actions of the NF-B and FoxO pathways 
downstream from mTORC2. (A) Cell multiplication was 
measured as in Fig. 3 E after purified DN thymocytes were 
transduced with pBMN-vector or pBMN-FoxO3(AAA) and 
cultured on OP9 cells ± DL1. Shown are the fold increases in 
cell numbers for the indicated periods (mean ± SD; two rep-
licate experiments, each performed in duplicate). (B and C) 
DN thymocytes nucleofected with siRNAs for FoxO1 and 
FoxO3a were transduced with vector or IKK2(SSEE), cultured 
for 6 d on OP9-DL1, and then analyzed as in Fig. 3 (C–E). 
Shown are CD4 and CD8 profiles for viable lymphoid cells in 
the Thy1.1+ gate (B), with inset numbers showing the per-
centage of DP cells produced by the culture, and fold in-
crease in cell number (C; representative data from B or mean ± 
SEM of the replicates in C; three separate experiments).  
The inset shows immunoblots of FoxO1 and FoxO3 in thymo-
cytes after nucleofection for RNAi. *, P < 0.05. (D) NF-B 
activity in IKK2(SSEE)-transfected thymocytes. Purified DN 
thymocytes were nucleofected with TK-Renilla luciferase, 
RE/AP-luciferase, and MiT-IKK2(SSEE) or its vector control 
and then cultured for 2 d on OP9 cells ± DL1. Shown  
are luciferase activities normalized for transfection  
efficiency (one luciferase assay result, representative of  
two separate experiments).
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mTORC2 facilitates Notch-driven T-ALL development
Physiological Notch signaling organizes developmental fates, 
yet gain of function mutations in Notch1 are common in can-
cer. More than 50% of the human T-ALL cells depend on 
ongoing Notch-initiated signals for their growth or viability 
(Weng et al., 2004). Accordingly, we tested the impact of 
Rictor on Notch-induced T-ALL using a mouse model in 
which hematopoietic bone marrow precursors were trans-
duced to express the Notch1 cleaved intracellular polypep-
tide (ICN1) and transplanted into recipient mice. As expected, 
Thy1+ CD4+CD8+ cells arose in the bone marrow and en-
tered the circulation by 2 wk after transplantation. Stochastic 
malignant transformation was then followed by tissue invasion 
and death. Whereas at most a modest impact of mTORC2 
deficiency on circulating Thy1+ CD4+CD8+ could be de-
tected, median survival almost doubled when donor marrow 
was programmed to delete rictor (Fig. 8, A–C). To explore 
the improvement in survival despite an equivalent emergence 
proliferation. BrdU incorporation after a short-term pulse 
showed DN thymocytes (especially DN4 cells) of WT mice 
to be highly proliferative in vivo (Fig. 7 F). In contrast, fre-
quencies of BrdU+ cells in each postexcision DN subset were 
reduced in cKO mice. Rates of proliferation after stimulation 
in vitro were similarly reduced for the Rictor-deficient thy-
mocytes, but their apoptosis was not affected by lack of 
mTORC2 (not depicted). The metabolic defects and block 
to DN4 progression caused by PDK1 deletion in thymocytes 
were associated with dramatically lower expression of several 
trophic receptors (Kelly et al., 2007). However, as in the re-
sults of cultures on OP9-DL1, PDK2 deficiency of Rictor 
cKO thymocytes led to only a very modest reduction of the 
transferrin receptor CD71 (not depicted), and mTORC2-
deficient DN thymocytes were of normal cell size (measured 
by FSC; not depicted) and glycolytic rate (Fig. 7 G). We infer 
that mTORC2 contributes to the production of a full T cell 
complement by promoting thymocyte proliferation.
Figure 6. Normal T cell development and 
thymocyte progression require Rictor.  
Representative or mean (±SEM) data (n = 9 
for each genotype) are shown. (A and B) 
Spleen and lymph node cells of 5–6-wk-old 
Lck-Cre, Rictorfl/fl mice versus WT controls.  
(A) Flow cytometry analyses, with frequencies 
(%) of CD4+ and CD8+ T cells presented as inset 
numbers (A), and T cell numbers from peripheral 
lymphoid organs (B). (B, C, E, and F) Shown 
are the mean (±SEM) calculated numbers of 
cells in the indicated subsets from spleen and 
pooled lymph nodes (B) or thymi (C, E, and F) of 
nine mice per genotype. *, P < 0.05; **, P < 0.01. 
(C–G) Thymocyte populations in cKO mice.  
(C) Thymic cellularity. Horizontal bars indicate 
the mean cell number. (D and E) Thymocyte 
subsets of the same Lck-Cre, Rictorfl/fl and  
WT mice as for A–C were determined using 
CD4 and CD8; numbers were calculated using 
cellularity of each thymus. (E [inset] and F) 
The same data plotted on a scale facilitating 
comparisons for DN and single-positive (SP) 
populations. Shown are the mean (±SEM; n = 9) 
calculated numbers of cells in the indicated 
subsets. (G) DN thymocytes of the same Lck-Cre, 
Rictorfl/fl and WT mice as for A–F or a separately 
matched cohort of Vav-Cre, Rictorfl/fl mice and 
WT controls (n = 8 for each genotype) were 
categorized into DN1–DN4 subsets by flow 
cytometry for CD25 and CD44 (DN1,  
CD44hiCD25; DN2, CD44hiCD25+; DN3,  
CD44loCD25+; and DN4, CD44loCD25). Shown 
are representative flow cytometric profiles of 
these markers on DN thymocytes of WT, Lck-
Cre cKO, and Vav-Cre cKO, with insets show-
ing the prevalence (%) in each quadrant (B) 
and mean frequencies (%) of the DN subsets. 
(H) Mean (±SEM) DN1–DN4 frequencies for 
the cohort (n = 8 each) of Vav-Cre cKO versus 
WT mice. *, P < 0.05.
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of function mutation (Fig. 8 D). Expression of NF-B target 
genes (Bcl2a1 and Nfkb2) were significantly decreased in the 
cKO T-ALL, whereas selected FoxO target genes (Il7ra, Sell, 
and S1p1) were not (Fig. 8 E). The NF-B–dependent che-
mokine receptor CCR7 has been reported as an important 
determinant of Notch-induced T-ALL pathogenesis and 
death because of a necessary and sufficient role in trafficking 
of the leukemic cells into tissue (Hasegawa et al., 2000; 
Jongen-Lavrencic et al., 2005; Buonamici et al., 2009), and Ccr7 
expression by mTORC2-deficient thymocytes was greatly 
reduced. Strikingly, circulating GFP+ Thy1+ cells from recipi-
ents of Notch-driven marrow programmed to delete Rictor 
showed significant decreases in Ccr7 gene expression (Fig. 8 E) 
while confirming the loss of Rictor mRNA. Moreover, deaths 
from leukemia were slower with Rictor-deficient cells after 
transfers of equal numbers of WT or cKO leukemic cells into 
irradiated recipients (Fig. 8 F). All together, this study pro-
vides evidence that PDK2 activity of mTORC2 is an impor-
tant determinant of the capacity of 
Notch to induce NF-B and CCR7, 
as well as accelerated tissue invasion 
and death in T-ALL.
of the preleukemic or leukemic cells in bone marrow and 
blood, we analyzed organ infiltration. Leukemic cells in liver, 
lung, and kidney were strikingly decreased by the Rictor loss 
Figure 7. Defects of Rictor-null thymo-
cyte development are cell autonomous. 
(A–E) Thymocytes were analyzed 2 mo after 
transplanting equal numbers of bone marrow 
cells from WT or Vav-Cre cKO mice (CD45.2) 
mixed with constant fractions of allotypically 
disparate (CD45.1) WT marrow cells and 
transferred into irradiated CD45.1 recipients. 
Shown are CD45.1 and CD45.2 profiles from 
one representative sample pair in one experi-
ment representative of two replicates  
(A and C) and the mean (±SEM) ratios of test 
cells (CD45.2)/internal WT standards (CD45.1; B), 
averaging the samples of the two indepen-
dent experiments (B, D, and E), comparing 
three versus three or two versus two recipi-
ents of WT versus cKO CD45.2 marrow.  
*, P < 0.05. (C–E) Within the CD45.1+ and 
CD45.2+ gates of B, CD4 and CD8 profiles (C), 
mean (±SEM) prevalence of DN and DP popula-
tions (D), and mean (±SEM) frequencies of DN 
subsets 1–4 (E). (F) Thymocytes were analyzed 
by flow cytometry after injection of BrdU into 
WT and Vav-Cre Rictor cKO mice. Shown are 
representative histograms from one of three 
independent experiments with the same  
results. Numbers denote the percentage  
of BrdU+ cells in the indicated gates  
(DN, CD4CD8; DN3, CD44loCD25+; and  
DN4, CD44loCD25 in the DN gate).  
(G) Normal glycolytic rate of Rictor-null  
thymocytes. Shown are mean (±SEM) data, 
averaging results of two independent  
experiments using five Lck-Cre versus five 
matched WT controls.
Table 1. Cellularity of thymi and spleens of Vav-Cre Rictorfl/fl 
mice
Cell type WT Vav-Cre Rictorfl/fl
Total thymocytes 237 ± 11 80 ± 12a
DN thymocytes 7.1 ± 0.5 5.3 ± 0.8a
DP thymocytes 206 ± 9.9 65 ± 11a
CD4 SP thymocytes 16 ± 1.0 4.8 ± 0.9a
CD8 SP thymocytes 7.6 ± 0.4 5.4 ± 0.8a
Total splenocytes 98 ± 10 37 ± 4.5a
CD4+ splenocytes 15 ± 1.7 4.6 ± 0.3a
CD8+ splenocytes 10 ± 1.0 3.6 ± 0.4a
SP, single positive. Mean ± SEM ×106 cells is shown.
aP < 0.05.
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Figure 8. mTORC2 facilitates Notch-induced T-ALL. (A) Shown are the Kaplan-Meyer survival curves for recipient mice after transplantation of ICN1-trans-
duced bone marrow progenitors of WT and cKO mice. (left) Cohorts using marrow of Lck-Cre+, Rictorfl/fl mice or littermate WT (Cre) controls (n = 8 vs. 8). (right) Co-
horts using marrow of Vav-Cre+, Rictorfl/fl mice or littermate WT controls (n = 8 vs. 8; for each cohort, P < 0.05 by statistical analysis as in Materials and methods, and 
P < 0.05 in statistical test of merged data of the two separate cohorts of cKO vs. WT). (B and C) Engraftment and leukemic cell characteristics. Shown are representa-
tive flow cytometry results for Thy1 and GFP (B) of bone marrow, spleen, and blood mononuclear cells (WT vs. cKO donor marrow) at 4 wk after transplantation, along 
with the CD4 and CD8 profiles of the same GFP+ Thy1.2+ gated cells (C). Shown are results from one representative mouse of WT versus cKO donor marrow (from data 
on >10 recipients of WT marrow and >10 cKO; >5 pairs for each Cre genotype), with the same results being obtained with marrow from Lck-Cre (n > 5 vs. > 5) and 
Vav-Cre (n > 5 vs. > 5) donor series. (D) Hematoxylin and eosin staining of liver, lung, and kidney sections from representative leukemic mice 4 wk after transplanta-
tion (sample spectrum and numbers as for C). Bar, 50 µm. (E) qRT2-PCR analyses of a subset of Notch, NF-B, and FoxO target genes. Shown are fold changes (±SEM) 
relative to WT leukemic cells (Thy1.2+ cells) isolated from recipient spleen (n = 3 vs. 3). *, P < 0.05. (F) Leukemic cells isolated 4–6 wk after transplantation of ICN1-
transduced progenitors were transferred into irradiated B6.PL-Thy1a recipients (5 × 105 GFP+ Thy1.2+ cells each). Shown are the Kaplan-Meyer survival curves merged 
from two independent transfers, each with three versus three recipients, after transfer of leukemic cells stemming from WT or Vav-Cre cKO marrow progenitors.
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residue in p70 S6K decreased after treatment of human T-ALL 
cells with a -secretase inhibitor (Chan et al., 2007). More-
over, ablation of one p70 S6K isoform, S6K1, caused a mod-
est delay in the onset of leukemia initiated by conditional loss 
of Pten (Tandon et al., 2011). In this regard, it is intriguing 
that in PTEN-deficient prostate cancer cells, the activity of 
Akt influenced the NF-B pathway by driving an association 
of Raptor with IKK- (Dan et al., 2008). This study is com-
patible with the present results because mTORC2 enhanced 
Akt activity and thus may be upstream from the Raptor-IKK 
mechanism in some settings. Finally, although our data reveal 
mTORC2 function as a precondition for full Notch signal-
ing in leading to the DP stage, Rictor may also act at Notch-
independent steps later in ontogeny (Tanigaki et al., 2004; 
Delgoffe et al., 2011).
Notch stimulates glycolysis, glucose uptake, and nutrient 
receptor expression by pre-T cells, thereby promoting the 
survival, growth, and differentiation of these cells (Ciofani 
and Zúñiga-Pflücker, 2005). The findings with mTORC2 
depletion provide evidence that glycolysis and nutrient 
receptor expression can be dissociated from a strong growth 
and differentiation phenotype, as these metabolic parameters 
were normal in Rictor-deficient thymocytes yet DL1-
stimulated proliferation and co-induction of CD4 and CD8 
were impaired. Previous work showed that these trophic re-
sponses to Notch depend on PDK1 (Kelly et al., 2007). Thus, 
when the Lck-Cre transgene was used for cell type–specific 
inactivation of the Pdk1 gene, cell size, survival, and CD71 
expression were all dramatically decreased, along with an al-
most complete block in the DN to DP transition (Kelly et al., 
2007). Both PDK1 and mTORC2 target Akt as a major 
downstream effector, but our data reveal several differences 
from the PDK1 effects on pre-T cells. In contrast to early 
PDK1 deficiency, rictor depletion did not substantially affect 
cell size, CD71 expression, or glycolytic rate in thymocytes or 
DN cells cultured on OP9-DL1. Thus, mTORC2 and its 
phosphorylation of Akt S473 appear dispensable for the 
Notch-induced trophic signaling in thymocytes. In addition 
to Akt, PDK1 phosphorylates and activates multiple AGC 
family kinases (S6K1, RSK, and PKC isoforms; Collins et al., 
2003), and the capacity to activate NF-B via TCR signaling 
also depends on PDK1 (Lee et al., 2005). A genetic approach 
that replaced WT PDK1 with a mutant enzyme supporting 
activation of Akt but not other AGC kinases did not restore 
thymocyte numbers despite normalizing nutrient receptor 
expression on pre-T cells (Kelly et al., 2007). Collectively, 
then, Notch and PDK1 require more than Akt activity alone 
when considering signaling at physiologically meaningful 
levels, but our findings imply that normal thymocyte progres-
sion requires a threshold level of Akt activity.
In this regard, it is intriguing that the functional conse-
quences of defective PDK2 activity analyzed here may also 
indicate a role for signal relays in addition to Akt under phys-
iological conditions. Although Myr-Akt transduction into 
Rictor-deficient DN thymocytes was able to drive cultures 
on OP9-DL1 to yield as many DP cells as were obtained 
DISCUSSION
Steps in the early thymic development of T cells are critically 
regulated by Notch in collaboration with other signals (Maillard 
et al., 2005). The evidence presented here shows that T lineage 
cells require an intact mTORC2 to fully execute biological 
effects that are driven by Notch. Pre-T cell proliferation and 
differentiation efficiency were impaired by loss of the gene 
encoding an essential subunit of mTORC2, and Akt and 
NF-B activities were diminished both in situ and in an ex-
perimental model driven by increased Notch engagement. 
NF-B activity and biological outcomes required mTORC2 
in an experimental context where other stimuli that also im-
pact PI3K-related or NF-B signaling (OP9-derived factors; 
IL-7; pre-TCR; etc) were comparable. Of note, a kinase that 
is a direct mTORC2 target mitigated key defects (NF-B 
levels, pre-T cell proliferation, and DP differentiation), pro-
viding evidence that the findings are caused by mTORC2 
rather than an alternative function of Rictor. The data suggest 
that Akt-dependent NF-B activity is important in relation 
to CCR7 expression and leukemia cell localization. Collec-
tively, these findings provide genetic evidence for vital roles 
of Rictor and mTORC2 in developmental and pathological 
effects of Notch, complementing previous indications that 
mTORC1 participates in these processes (Luo et al., 1994; 
Janes et al., 2010; Tandon et al., 2011).
Rapamycin causes significant thymic atrophy by repress-
ing growth and proliferation of thymocytes (Luo et al., 1994), 
and mTOR is the known enzymatic target of this pharma-
ceutical agent (Laplante and Sabatini, 2009). However, little 
is known about relative roles of the two classes of mTOR com-
plex in thymic T cell development, or in the context of Notch 
signaling or Notch-initiated pathologies. Only mTORC1 is 
acutely inhibited by rapamycin because of its Raptor subunit, 
but chronic administration of rapamycin over time led to im-
pairment of Akt(S473) phosphorylation (Sarbassov et al., 2006; 
Lee et al., 2010; Delgoffe et al., 2011). Thus, the chronic effects 
of rapamycin on the thymus might be attributable either to 
mTORC1, mTORC2, or both. The finding that mTORC2 
depletion impaired thymocyte numbers and created a bottle-
neck impairing the efficiency of DN to DP differentiation, 
together with work indicating that a week of in vivo rapamycin 
treatment eliminated phosphorylation of Akt S473 (Sarbassov 
et al., 2006), suggests that at least some of the rapamycin 
effect can be attributed to mTORC2. The need for mTORC2 
in execution of a Notch-initiated signal and the thymic pheno-
type of Lck-Cre, Rictorfl/fl mice parallel the results with mice in 
which the main transcriptional target of all four Notch pro-
teins, RBP-J, was deleted using the same Cre transgene. In 
this work (Tanigaki et al., 2004), DN thymocyte numbers 
decreased substantially because of a defect of the proliferative 
burst, and a bottleneck in the DN to DP transition similar to 
that of mTORC2-deficient thymocytes was present.
Nonetheless, both mTOR complexes probably play a 
role downstream from Notch. First, the distortion of the DN 
to DP ratio was greater in RBP-J–deficient mice than the 
Rictor cKO. Second, phosphorylation of the mTORC1 target 
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Notch inhibitors (Searfoss et al., 2003; Real and Ferrando, 
2009), the different structures and functions of the mTOR 
signaling complexes, and the inherent capacity of mTORC1 
inhibitors to increase PI3K signal initiation as the result of re-
lief of negative feedback at an apical level (Bhaskar and Hay, 
2007; Guertin and Sabatini, 2009). Using enzymatic inhibitors 
of both mTOR complexes, or of mTOR and PI3K, offers 
new promise (Real et al., 2009; Carayol et al., 2010; Chiarini 
et al., 2010; Janes et al., 2010; Altman et al., 2011). The ge-
netic evidence that Rictor deficiency protects against T-ALL, 
independent from apparent changes in mTORC1 activity, 
supports the need to block mTORC2. In addition, the find-
ing suggests that more selective inhibition of mTORC2 
might offer an independent therapeutic approach with lower 
inherent toxicities.
MATERIALS AND METHODS
Mice and bone marrow transplantation. (B6 × 129S/v) Rictorfl/fl mice 
(Shiota et al., 2006) were bred to a B6 (C57BL/6-J) background and crossed 
with transgenic mice (C57BL/6) expressing Cre recombinase under control 
of the proximal Lck promoter (Lck-Cre; n ≥ 4 for Rictor backcrosses to B6) or 
Vav1 promoter (Vav-Cre; n ≥ 6), and PCR genotyping was performed as de-
scribed previously (Lee et al., 2010). All mice were housed in individually 
ventilated micro-isolator cages in specific pathogen–free conditions and used 
as monitored by the Vanderbilt University Office of Animal Welfare Assur-
ance after approval of experimental protocols by the Institutional Animal 
Care and Use Committee. Because of evidence of a substantial heterozygote 
phenotype and no evidence of an impact of the Cre transgenes on Rictor+/+ 
cells, experiments were performed either comparing Cre littermate con-
trols with Cre+ Rictorfl/fl mice or, for further validation, parallel genetic stock 
at similar backcross generations but Cre+ Rictorfl/fl versus Cre+ Rictor+/+. For 
mixed competitive chimeras, bone marrow cells were obtained from B6 
(CD45.2) WT and Vav-Cre, Rictorfl/fl as well as B6-CD45.1 mice (ages 6–8 wk). 
After depletion of T and B lineage cells using microbeads, 4 × 106 Thy1 
B220 marrow cells were mixed with equal numbers of CD45.1 marrow 
cells and injected intravenously into lethally irradiated (10 Gy in two di-
vided doses) B6-CD45.1 recipients. For Notch-driven leukemia experi-
ments, bone marrow cells were obtained from mice 4 d after treatment with 
150 mg/kg 5-FU (Campese et al., 2006), incubated (2 d) in DME supple-
mented with 15% FBS, 10 ng/ml IL-3, 20 ng/ml IL-6, and 50 ng/ml stem 
cell factor, and transduced with MiGR1-ICN1 (provided by W. Pear, Uni-
versity of Pennsylvania, Philadelphia, PA; Aster et al., 2000). Each lethally 
irradiated B6.Thy1a recipient (prepared as above) received a mixture of 5 × 105 
unmanipulated bone marrow cells along with half of the ICN1-transduced 
cells. Irradiated mice were maintained on water supplemented with amoxi-
cillin for 2 wk after transplantation.
Antibodies and reagents. Cytokines and antibodies against cell surface 
markers were purchased from BD except for recombinant mouse IL-7 (Leinco 
Technologies) and biotinylated anti-Thy1.1 (eBioscience). Primary antibod-
ies for immunoblotting were obtained from Cell Signaling Technology except 
for anti-rictor (Bethyl Laboratories), whereas infrared dye–conjugated second 
antibodies were obtained from Rockland or LI-COR Biosciences. Anti-CD4 
and anti-CD8 magnetic microbeads were obtained from Miltenyi Biotec, 
and streptavidin-conjugated IMag particles were purchased from BD.
Cell culture. Thymocytes were cultured in complete medium containing 
10% FBS and supplemented as described previously (Lee et al., 2010). For 
in vitro differentiation of DN thymocytes, monolayers of OP9-DL1 and OP9-
control cells (provided by S. Cleveland, U. Dave, and J.C. Zúñiga-Pflücker, 
Vanderbilt University, Nashville, TN; Ciofani and Zúñiga-Pflücker, 2005) 
were maintained in MEM (Sigma-Aldrich) supplemented with 15% FBS. 
CD4CD8 DN subsets were purified from pooled thymocytes by CD8 
with the Myr-Akt–transduced WT cells, epistasis with the 
more physiological Akt mutant, Akt(DD), led only to num-
bers equivalent to vector-transduced WT cells. Because PKC 
isoforms are targets of mTORC2 kinase activity (Facchinetti 
et al., 2008; Ikenoue et al., 2008; Lee et al., 2010), it is attrac-
tive to speculate that the PKCs expressed in developing thy-
mocytes need to be sufficiently active unless Akt activity is at 
the very high level achieved by Myr-Akt. Pre-TCR signal-
ing leads to activation of the NF-B pathway in thymocytes 
to facilitate survival (Voll et al., 2000), so it is likely that the 
increased Akt activity caused by HM phosphorylation oper-
ates in part through NF-B. However, our findings also in-
dicate that Akt phosphorylation of FoxO proteins amplifies 
DN thymocyte proliferation. This mechanism would mirror 
the model inferred for regulation of the T reg cell fate choice 
at later stages in the T lineage, i.e., Akt regulation of FoxO 
proteins whose binding to regulatory chromatin at the Foxp3 
locus is vital for induction of FoxP3 expression (Harada et al., 
2010; Ouyang et al., 2010).
In addition to observing defects in Notch-induced pre-
T cell proliferation and differentiation, Rictor depletion sub-
stantially prolonged survival in the setting of extreme Notch 
drive leading to death from leukemia. In this model of T-ALL, 
the cancer preferentially arises from pre-T type cells to evade 
an Ink4a/Arf-imposed restriction (Volanakis et al., 2009; 
Medyouf et al., 2010), but there are several phases of leukemic 
cells across time after bone marrow transfer (Campese et al., 
2006). The initial emergence of abnormal GFP+ cells into 
blood and their rising prevalence over time were similar in 
recipients of WT and cKO marrow, whereas disease was still 
delayed upon secondary transfer of leukemic cells into new 
recipients. These findings suggest that the protective effect of 
mTORC2 deficiency in this setting was exerted at a later step 
in oncogenic progression or disease. Of note, mTORC2 
transduced signals that regulate expression of the NF-B–
dependent Ccr7 gene in the leukemic cells, extending the in-
sight that mortality from ICN1-induced T-ALL depended 
on CCR7-mediated chemotaxis into tissues (Buonamici 
et al., 2009). Our evidence that NF-B activity and expression 
of other NF-B target genes (Nfkb2 and Bcl2a1) are reduced 
in the Rictor cKO cells indicates that NF-B transcription 
factors are likely to be key mediators of the mTORC2 con-
tribution to T-ALL in this setting. The findings with trans-
duction of constitutively active Akt mutants into the impaired 
Rictor cKO thymocytes indicate that this kinase can suffice to 
drive a restoration of NF-B activity. However, mTORC2 
was also found to be important for regulation of the amount 
of Hes1 mRNA induced by Notch. In light of evidence that 
Hes1 appears to serve as a direct repressor of Cyld (Cylindroma-
tosis) gene expression, with CYLD in turn inhibiting NF-B 
pathway activity, the Akt impact on NF-B and T-ALL may 
involve collaboration of Akt with other signaling compo-
nents (Espinosa et al., 2010).
Central challenges facing chemotherapy for T-ALL or other 
Notch-dependent tumors (Ranganathan et al., 2011) include 
the dose-limiting toxicities of -secretase and perhaps other 
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by flow cytometry. Migrated cells of each subset were calculated as a per-
centage of their input number.
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